Tezcat Biosciences
Pre-clinicalTezcat Biosciences is developing novel receptor-independent drug delivery technology for Ras-activated cancers
Founded
2021
Focus
Drug Delivery
About
Tezcat Biosciences is developing novel receptor-independent drug delivery technology for Ras-activated cancers
Funding History
1Total raised: $4.5M
Seed$4.5MUndisclosedJun 15, 2023
Company Info
TypePrivate
Founded2021
LocationCambridge, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile